Licensing
In addition to helping clients secure protection for their own intellectual property, BSKB represents companies looking to license intellectual property rights to others to expand markets for their goods and services or to obtain licenses from others for more freedom to sell a broader range of goods or services. BSKB also assists clients who look to cross-license intellectual property rights to create joint cooperation agreements with other companies or, as part of a more complex litigation scenario, to settle disputes with other companies.
BSKB provides legal opinions for both prospective licensors and licensees to ensure companies can move forward with licensing and acquisition plans with confidence in the value of the related intellectual property. BSKB also assists clients with an inventory and valuation of intellectual property rights and identifying and targeting potential licensing targets, as well as drafting simple to highly complex intellectual property licensing agreements.
Attorneys and Professionals
Related Articles
-
February 16, 2023
Amgen v. Sanofi – When Functional Language in Patents Malfunctions
Law360
How High Court Amgen Case Could Alter Patent Enablement
-
December 29, 2022
Key Topics in IP for 2023
IPWatchdog
Eugene Perez is quoted in IPWatchdog discussing key issues to watch in 2023
Related Presentations
-
March 8, 2023
Duty of Disclosure and Duty of Reasonable Inquiry
-
February 22, 2023
Pushing Back against Obviousness Rejections Unsupported by Evidence and Lacking Reasoned Explanations: A discussion of In re Google LLC.
-
February 8, 2023
LKQ CORP, KEYSTONE V. GM GLOBAL No. 2021-2348 (Fed. Cir. 2023)
-
November 16, 2022
Overview of AI Application and Related Issues
Recent News
-
February 27, 2023
USPTO ANNOUNCEMENT
The electronic patent grant will be the official statutory patent grant effective April 18, 2023.
-
December 29, 2022
USPTO DOCX ANNOUNCEMENT
The U.S. Patent and Trademark Office (USPTO) has delayed the implementation of the non-DOCX filing surcharge until April 3, 2023.